SHOULD NOVOBIOCIN BE CLINICALLY RE-EVALUATED

被引：18

作者：

JONES, RN ^{[1
]}

机构：

[1] CLIN MICROBIOL INST INC,TUALATIN,OR

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1989年 / 12卷 / 04期

关键词：

D O I：

10.1016/0732-8893(89)90105-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：363 / 365

页数：3

共 13 条

[1] SERIOUS REACTIONS TO NOVOBIOCIN [J].

BRIDGES, RA ;

BERENDES, H ;

GOOD, RA .

JOURNAL OF PEDIATRICS, 1957, 50 (05) :579-585

[2] STEADY-STATE SERUM PHARMACOKINETICS OF NOVOBIOCIN AND RIFAMPIN ALONE AND IN COMBINATION [J].

DRUSANO, GL ;

TOWNSEND, RJ ;

WALSH, TJ ;

FORREST, A ;

ANTAL, EJ ;

STANDIFORD, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (01) :42-45

[3]

FINLAND M, 1956, ANTIBIOTIC THERAPY S, P97

[4] INVITRO ACTIVITY OF NOVOBIOCIN AND RIFAMPIN ALONE AND IN COMBINATION AGAINST OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].

JOHNSTON, BL ;

KWOK, RYY ;

MULLIGAN, ME .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (03) :137-147

[5] INVITRO EVALUATION OF RAMOPLANIN (A16686 OR MDL62198) - A NEW DEPSIPEPTIDE COMPLEX FOR POTENTIAL TOPICAL USE [J].

JONES, RN ;

BARRY, AL .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (03) :279-282

[6]

KIRBY WMM, 1956, ARCH INTERN MED, V98, P1, DOI 10.1001/archinte.1956.00250250007001

[7] INTERNATIONAL RECOGNITION OF METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS [J].

THOMPSON, RL ;

WENZEL, RP .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) :925-926

[8]

Walsh T. J., 1985, J ANTIMICROB CHEMOTH, V16, P1

[9] OBSERVATIONS RELATING TO AN INTER-HOSPITAL OUTBREAK OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - ROLE OF ANTIMICROBIAL THERAPY IN INFECTION CONTROL [J].

WARD, TT ;

WINN, RE ;

HARTSTEIN, AI ;

SEWELL, DL .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1981, 2 (06) :453-459

[10]

WELCH H, 1956, Antibiotic Med Clin Ther (New York), V3, P27

← 1 2 →